SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-14-000085
Filing Date
2014-05-09
Accepted
2014-05-09 16:17:04
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nano_10q.htm 10-Q 205819
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 exhibit_31-1.htm EX-31.1 18693
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S. C. SECTION 1350 exhibit_32-1.htm EX-32.1 6541
  Complete submission text file 0001520138-14-000085.txt   1233655

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nati-20140331.xml EX-101.INS 107814
5 XBRL SCHEMA FILE nati-20140331.xsd EX-101.SCH 11880
6 XBRL CALCULATION FILE nati-20140331_cal.xml EX-101.CAL 15322
7 XBRL DEFINITION FILE nati-20140331_def.xml EX-101.DEF 18400
8 XBRL LABEL FILE nati-20140331_lab.xml EX-101.LAB 92786
9 XBRL PRESENTATION FILE nati-20140331_pre.xml EX-101.PRE 69807
Mailing Address 9511 COLLINS AVENUE SUITE 807 SURFSIDE FL 33154
Business Address 9511 COLLINS AVENUE SUITE 807 SURFSIDE FL 33154 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-190635 | Film No.: 14829329
SIC: 2834 Pharmaceutical Preparations